Phibro Anl Htlh A (PAHC) Stock Price, Quote & News

Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, su...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 201 329 7300

Website: www.pahc.com

Address:

Glenpointe Centre East, 3rd Floor Suite 21 300 Frank West Burr Boulevard, Teaneck, United States

ZacksResearch Jan. 15 at 4:18 PM

$PAHC has surged 90.9% in the past year! 🚀 What's fueling this impressive rally? 📈 Vaccine business net sales up 25% in the first quarter of fiscal 2026, driven by growth in poultry products in Latin America and higher international demand. 🌍 Expanding vaccine operations in high-growth regions like Latin America and Asia. Discover the full story behind PAHC's momentum here 👉 https://www.zacks.com/stock/news/2818095/phibro-animal-health-stock-climbs-909-in-a-year-whats-driving-it?cid=sm-stocktwits-2-2818095-body-29087&ADID=SYND_STOCKTWITS_TWEET_2_2818095_BODY_29087

0 · Reply

ZacksResearch Jan. 15 at 3:18 PM

$PAHC up 90.9% in a year — and this rally isn’t random. 🚀 Shares are surging on booming vaccine sales, new capacity coming online in Brazil, and rapid growth across emerging markets — a powerful combo driving momentum. Find out what’s really fueling PAHC’s breakout 👉 https://www.zacks.com/stock/news/2818095/phibro-animal-health-stock-climbs-909-in-a-year-whats-driving-it?cid=sm-stocktwits-2-2818095-teaser-29082&ADID=SYND_STOCKTWITS_TWEET_2_2818095_TEASER_29082

0 · Reply

TheRealShortSqueezy Jan. 14 at 2:30 PM

$PETV Just Dropped News 📰 Digital Landia’s AgenticPet surpassed 1,000+ active beta users in under 72 hours, signaling strong demand for AI-powered preventive pet healthcare. Key highlights: 🔸1,000+ beta users onboarded under 72 hours 🔸 Confirms demand for proactive, AI-driven pet health monitoring 🔸 Powered by 10 specialized AI agents (Veterinarian, Behaviorist, Geneticist, Radiologist, etc.) 🔸 Early users report detection of health, stress, and behavioral issues previously unnoticed 🔸 Backed by an exclusive 10-year partnership with PetVivo Holdings 🔸 Partnership provides access to ~8,500 veterinary clinics nationwide Momentum is building and PETV sits at the center of AI-driven preventive pet care. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC

0 · Reply

TheRealShortSqueezy Jan. 6 at 2:35 PM

$PETV : From Vet Devices to AI Powerhouse 🐾 PetVivo Holdings develops FDA approved regenerative veterinary devices and is now leveraging its installed base to launch a high-margin AI diagnostic platform. The foundation➡️ The Device Business: ➖ SPRYNG & PrecisePRP FDA-approved regenerative veterinary devices ➖1,000+ veterinary clinics actively using PetVivo products ➖7,300+ veterinarians in the distribution network ➖30% gross margins with stable, repeat revenue The Catalyst ➡️The AI Platform: ➖ http://PetVivo.ai launching Q1 2026 (≈ 90 days away) ➖ 10 specialized AI diagnostic agents ➖ 80–90% gross margins, a massive step-change from devices The market opportunity: Wall Street is valuing PetVivo as a low multiple veterinary device company (~$45M market cap), while the company is evolving into an AI-driven platform that could justify a $360M – $1.35B+ valuation. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC

1 · Reply

ProverbsP Dec. 27 at 5:41 AM

$PAHC Markets appear to be rewarding companies that show durable execution rather than rapid narrative shifts. Margins must hold as the company navigates cost pressure. Credible progress tends to compress risk premiums. Execution quality becomes the defining catalyst from here.

0 · Reply

ZacksResearch Dec. 16 at 1:34 PM

$PAHC surged 93.7% in the past year — is the rally sustainable? 🚀 🐔 Strong growth in Animal Health, with MFA revenues up 81% in Q1 FY26 in nutritional specialties and vaccines 🌍 Expanding vaccine business and global footprint in approximately 90 countries 📈 Zacks Rank #1 and a 23.7% earnings surprise last quarter Discover why PAHC could keep climbing 👉 https://www.zacks.com/stock/news/2804780/is-phibro-animal-health-stock-a-smart-addition-to-your-portfolio-now?cid=sm-stocktwits-2-2804780-body-24958&ADID=SYND_STOCKTWITS_TWEET_2_2804780_BODY_24958

0 · Reply

ZacksResearch Dec. 16 at 12:07 PM

$PAHC riding a powerful Animal Health wave — but risks aren’t gone 🚀 Animal Health momentum, vaccine growth, and rising emerging market demand are driving the story, even as macro pressure and competitive risks continue to linger in the background. See the full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2804780/is-phibro-animal-health-stock-a-smart-addition-to-your-portfolio-now?cid=sm-stocktwits-2-2804780-teaser-24922&ADID=SYND_STOCKTWITS_TWEET_2_2804780_TEASER_24922

0 · Reply

ZacksResearch Dec. 10 at 2:41 PM

$PAHC up 59.6% so far this year — what's driving the surge? 🚀 🐾 Animal Health biz momentum & vaccine growth 🌍 Expanding in high-growth regions like Brazil & Southeast Asia 📈 Fiscal 2026 EPS expected to jump 32.1% Discover the full growth story here 👉 https://www.zacks.com/stock/news/2802112/phibro-animal-health-stock-climbs-596-ytd-whats-driving-it?cid=sm-stocktwits-2-2802112-body-24201&ADID=SYND_STOCKTWITS_TWEET_2_2802112_BODY_24201

0 · Reply

ZacksResearch Dec. 10 at 12:35 PM

$PAHC’s 59% YTD surge — is this momentum just getting started? Animal Health is firing on all cylinders, with booming vaccines and global gains even as competition heats up. That kind of strength is hard to ignore. Full breakdown here 👉 https://www.zacks.com/stock/news/2802112/phibro-animal-health-stock-climbs-596-ytd-whats-driving-it?cid=sm-stocktwits-2-2802112-teaser-24132&ADID=SYND_STOCKTWITS_TWEET_2_2802112_TEASER_24132

0 · Reply

BEATOFtheMARKET Dec. 2 at 7:54 PM

$OXSQ $PACK $PAGS $PAHC $PAM Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥 Math don't lie 🔥

0 · Reply

Phibro Animal Health Corporation Announces Leadership Transition

Nov 6, 2025, 2:36 PM EST - 2 months ago

Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript

Nov 5, 2025, 4:22 PM EST - 2 months ago

Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance

Nov 4, 2025, 4:10 PM EST - 2 months ago

Phibro Animal Health Corporation Declares Quarterly Dividend

Oct 30, 2025, 1:00 PM EDT - 2 months ago

Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs

Oct 29, 2025, 4:00 PM EDT - 2 months ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results

Oct 9, 2025, 4:30 PM EDT - 3 months ago

Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs

Sep 9, 2025, 5:21 PM EDT - 4 months ago

Phibro Animal Health Corporation (PAHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 4:00 PM EDT - 4 months ago

Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference

Sep 2, 2025, 9:15 AM EDT - 4 months ago

Phibro Animal Health: Zoetis Growth, Valuation Still Attractive

Aug 28, 2025, 12:29 PM EDT - 5 months ago

Phibro Animal Health Corporation (PAHC) Q4 2025 Earnings Conference Call Transcript

Aug 27, 2025, 4:57 PM EDT - 5 months ago

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

Aug 20, 2025, 4:00 PM EDT - 5 months ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results

Jul 7, 2025, 5:00 PM EDT - 6 months ago

Overlooked Stock: PAHC Taps 4-Year High

Jul 7, 2025, 2:30 PM EDT - 6 months ago

Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost

Jun 25, 2025, 4:19 AM EDT - 7 months ago

Phibro Animal Health: The Animal Is Unleashed

May 22, 2025, 4:00 PM EDT - 8 months ago

Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference

May 10, 2025, 3:40 PM EDT - 8 months ago

Phibro Animal Health Corporation (PAHC) Q3 2025 Earnings Call Transcript

May 7, 2025, 4:30 PM EDT - 9 months ago

Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

Apr 23, 2025, 4:00 PM EDT - 9 months ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

Mar 5, 2025, 4:00 PM EST - 11 months ago

Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference

Feb 20, 2025, 4:00 PM EST - 11 months ago

Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit

Feb 13, 2025, 8:15 AM EST - 1 year ago

Phibro Animal Health Is Cruising With Its Recent Zoetis Acquisition

ZTS

Feb 6, 2025, 1:26 PM EST - 1 year ago

Phibro Animal Health Corporation (PAHC) Q2 2025 Earnings Call Transcript

Feb 5, 2025, 4:30 PM EST - 1 year ago

Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance

Jan 23, 2025, 4:45 PM EST - 1 year ago

Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors

Jan 22, 2025, 4:30 PM EST - 1 year ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results

Nov 8, 2024, 8:31 PM EST - 1 year ago

Phibro Animal Health Corporation (PAHC) Q1 2025 Earnings Call Transcript

Oct 31, 2024, 4:10 PM EDT - 1 year ago

Phibro Animal Health Corporation Completes Acquisition of Zoetis' Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products

ZTS

Aug 29, 2024, 6:08 PM EDT - 1 year ago

Phibro Animal Health Corporation (PAHC) Q4 2024 Earnings Call Transcript

Aug 14, 2024, 4:00 PM EDT - 1 year ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2024 Results

Jun 5, 2024, 4:00 PM EDT - 1 year ago

Phibro Animal Health Corporation Releases Third Annual ESG Report: Connections that Advance Animal Health, Nutrition and Sustainability

May 20, 2024, 4:00 PM EDT - 1 year ago

Phibro Animal Health Corporation to Participate in Stifel Dental and Animal Health (Jaws & Paws) Conference

May 10, 2024, 1:43 PM EDT - 1 year ago

Phibro Animal Health Corporation (PAHC) Q3 2024 Earnings Call Transcript

Apr 28, 2024, 6:30 PM EDT - 1 year ago

Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health

ZTS

Feb 29, 2024, 4:00 PM EST - 2 years ago

Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference

Feb 14, 2024, 4:00 PM EST - 2 years ago

Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit

Feb 8, 2024, 3:55 PM EST - 2 years ago

Phibro Animal Health Corporation (PAHC) Q2 2024 Earnings Call Transcript

Feb 6, 2024, 8:30 AM EST - 2 years ago

Phibro Animal Health Corporation Announces Chief Financial Officer Changes

Nov 20, 2023, 8:53 PM EST - 2 years ago

Phibro Animal Health: Vaccine App And Analysts' Expectations Imply Undervaluation

Nov 10, 2023, 11:35 AM EST - 2 years ago

Phibro Animal Health Corporation (PAHC) Q1 2024 Earnings Call Transcript

Nov 7, 2023, 10:23 AM EST - 2 years ago

Phibro Animal Health Corporation Reiterates Safety of Mecadox® and Intent to Defend its Use for Customers

Aug 31, 2023, 1:27 PM EDT - 2 years ago

Phibro Animal Health Corporation (PAHC) Q4 2023 Earnings Call Transcript

Jul 31, 2023, 4:00 PM EDT - 2 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2023 Results

May 8, 2023, 4:01 PM EDT - 2 years ago

Phibro Issues Second Environmental, Social and Governance Report

May 6, 2023, 5:28 PM EDT - 2 years ago

Phibro Animal Health Corporation (PAHC) Q3 2023 Earnings Call Transcript

May 3, 2023, 4:30 PM EDT - 2 years ago

Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results

Apr 13, 2023, 4:00 PM EDT - 3 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Financial Results

Apr 5, 2023, 4:00 PM EDT - 3 years ago

Phibro Animal Health Corporation to Participate in Bank of America Securities 2023 Health Care Conference.

Feb 14, 2023, 4:00 PM EST - 3 years ago

Phibro Animal Health Corporation to Participate in Bank of America 2023 Animal Health Summit

ZacksResearch Jan. 15 at 4:18 PM

0 · Reply

ZacksResearch Jan. 15 at 3:18 PM

0 · Reply

TheRealShortSqueezy Jan. 14 at 2:30 PM

0 · Reply

TheRealShortSqueezy Jan. 6 at 2:35 PM

1 · Reply

ProverbsP Dec. 27 at 5:41 AM

0 · Reply

ZacksResearch Dec. 16 at 1:34 PM

0 · Reply

ZacksResearch Dec. 16 at 12:07 PM

0 · Reply

ZacksResearch Dec. 10 at 2:41 PM

0 · Reply

ZacksResearch Dec. 10 at 12:35 PM

0 · Reply

BEATOFtheMARKET Dec. 2 at 7:54 PM

$OXSQ $PACK $PAGS $PAHC $PAM Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥 Math don't lie 🔥

0 · Reply

BEATOFtheMARKET Nov. 23 at 3:45 PM

$OXSQ 🔥 $PACK $PAGS $PAHC $PAM

0 · Reply

BEATOFtheMARKET Nov. 17 at 10:59 AM

$OTTR $OUT $PAAS $PAHC $PAM

0 · Reply

JarvisFlow Nov. 7 at 8:06 PM

JP Morgan updates rating for Phibro Animal Health ( $PAHC ) to Overweight, target set at 45 → 50.

0 · Reply

ZacksResearch Nov. 3 at 5:44 PM

$INFU surges 75.2% in 3 months — what's fueling the rally? 🚀 🔥 Strong Patient Services & Device Solutions performance 📈 Higher treatment volume and increased third-party payer collections in Oncology and Wound Care boost revenues 🔧 Strategic restructuring with GE Healthcare underway Discover why $INFU is outperforming its peers like $PAHC, $PODD, and $LMAT 👉 https://www.zacks.com/stock/news/2783746/can-strength-in-rental-business-drive-infu-stock-before-q3-earnings?cid=sm-stocktwits-2-2783746-body-19156&ADID=SYND_STOCKTWITS_TWEET_2_2783746_BODY_19156

0 · Reply

BullishBanana Oct. 26 at 6:56 PM

$QNCX $PAHC enters a licensing agreement with Lighthouse Pharmaceuticals (Quince Therapeutics has a 7.5% ownership in LHP). https://investors.pahc.com/press-releases/press-release-details/2025/Phibro-Animal-Health-Corporation-Announces-Licensing-Agreement-with-Lighthouse-Pharmaceuticals-Inc--for-Innovative-Periodontal-Health-Asset-for-Dogs/default.aspx

0 · Reply

ADXAdmiral Oct. 5 at 4:20 PM

$PAHC Healthcare technology. Testing key support. Volume pattern shows distribution. Growth concerns persisting.

0 · Reply

ZacksResearch Sep. 25 at 2:08 PM

$PAHC surges 82.1% YTD — what's driving this incredible rally? 🚀 🐾 Strong Animal Health momentum 💊 Vaccine sales up 21% YoY 🌎 Expanding global footprint 📈 Fiscal 2025 EPS estimate up 11.7% in 30 days Discover more on this bullish setup 👉 https://www.zacks.com/stock/news/2756834/phibro-animal-health-stock-surges-821-ytd-whats-fueling-it?cid=sm-stocktwits-2-2756834-body-14105&ADID=SYND_STOCKTWITS_TWEET_2_2756834_BODY_14105

0 · Reply

ZacksResearch Sep. 25 at 12:07 PM

$PAHC up 82.1% YTD — too hot to ignore 🚀 The stock’s massive run has investors asking what’s driving the momentum and whether it’s sustainable. Full breakdown on what’s fueling the surge 👉 https://www.zacks.com/stock/news/2756834/phibro-animal-health-stock-surges-821-ytd-whats-fueling-it?cid=sm-stocktwits-2-2756834-teaser-14059&ADID=SYND_STOCKTWITS_TWEET_2_2756834_TEASER_14059

0 · Reply

RunnerSignals Sep. 11 at 12:54 PM

Bulls on Parade! $UTHR $ORCL $PAHC $CF $IRM all strutting their stuff Watch the dance, not just the flash. https://stocksrunner.com/news/2025-09-11-daily-market-pulse-advanced-technical-analysis-and-stock-trading-strategies

0 · Reply

fer69 Sep. 10 at 10:03 PM

$PAHC liquidated my whole position today … had a great run from $12 average .. 500 shares were assigned at $15 + premium and 500 at $41 .. will sell 200 shares of $PETS at a loss of over 45% by December to offset gains on same sector ..

0 · Reply

ZacksResearch Sep. 10 at 3:42 PM

$PAHC has soared 101.1% in the past year! 🚀 Is it time to double down? 🔹 Animal Health sales up 53% in fiscal Q4, boosted by $ZTS acquisition and strong international demand 🔹 Mineral Nutrition sees growth with increased demand for copper and trace minerals 🔹 Solid solvency with only $16M in short-term debt Full insights on this Zacks Rank #1 stock here 👉 https://www.zacks.com/stock/news/2749278/heres-why-you-should-add-pahc-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2749278-body-11742&ADID=SYND_STOCKTWITS_TWEET_2_2749278_BODY_11742

0 · Reply

ZacksResearch Sep. 10 at 2:42 PM

$PAHC looks like a buy right now 🐂 Animal Health sales are climbing thanks to the Zoetis acquisition, and both Mineral Nutrition and Performance Products are rebounding. Full breakdown here 👉 https://www.zacks.com/stock/news/2749278/heres-why-you-should-add-pahc-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2749278-teaser-11739&ADID=SYND_STOCKTWITS_TWEET_2_2749278_TEASER_11739

0 · Reply

Market Cap	1.62B
Revenue (ttm)	1.30B
Net Income (ttm)	48.26M
EPS (ttm)	N/A
PE Ratio	16.38
Forward PE	14.65
Profit Margin	3.72%
Debt to Equity Ratio	2.38

Volume	218,929
Avg Vol	286,164
Day's Range	N/A - N/A
Shares Out	40.53M
Stochastic %K	73%
Beta	0.79
Analysts	Sell
Price Target	$41.00